Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial.

Ahmed, Asra

Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial. [electronic resource] - The Lancet. Haematology Dec 2019 - e630-e637 p. digital

Publication Type: Clinical Trial; Journal Article

2352-3026

10.1016/S2352-3026(19)30156-5 doi


Adult
Female
Historically Controlled Study
Humans
Lymphohistiocytosis, Hemophagocytic--blood
Male
Middle Aged
Neutrophils--pathology
Nitriles
Pilot Projects
Platelet Count
Pyrazoles--therapeutic use
Pyrimidines
Splenomegaly--blood
Survival Analysis